Health

Results: 805-816 of 8097

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions

Sobi to Showcase Scientific advances and Commitment to Haematology at ASH 2025

SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2

PR Newswire associated0

/C O R R E C T I O N -- Seegene Inc./

ZINZINO AB (PUBL.): Zinzino AB changes Certified Adviser to Tapper Partners AB

A Nation Under Pressure: New Hilo Report Reveals Stark Gaps in UK Blood Pressure Awareness, Behaviour and Monitoring

Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body